<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04106128</url>
  </required_header>
  <id_info>
    <org_study_id>18-PP-15</org_study_id>
    <nct_id>NCT04106128</nct_id>
  </id_info>
  <brief_title>Prevalence, Impact and Reversibility of Acute Diaprhagmatic Dysfunction in Acute Respiratory Detresse</brief_title>
  <acronym>PIRD-DRA</acronym>
  <official_title>Prevalence, Impact and Reversibility of Acute Diaprhagmatic Dysfunction in Acute Respiratory Detresse Measured by Diaphragmatic Echogaphy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The diaphragm is a fine striated muscle with both extra respiratory and respiratory
      functions. It does most of the breathing work in interaction with the accessory respiratory
      muscles, the rib cage and the abdomen. Its activity can be measured by the transdiaphragmatic
      pressure generated by the magnetic stimulation of phrenic nerves (gold standard). It has been
      shown in the literature that diaphragmatic ultrasound, via the measurement of diaphragmatic
      excursion and especially the thickening fraction, is an easily accessible, non-invasive,
      reproducible and relevant technique for evaluating acute diaphragmatic dysfunction in
      resuscitation patients.

      The objective of this project is to evaluate the prevalence of diaphragmatic dysfunction at
      admission in patients hospitalized in intensive care / respiratory intensive care unit for
      hypercapnic and/or hypoxic acute respiratory distress and requiring ventilatory support by
      non-invasive ventilation or high flow oxygen therapy. A subgroup analysis will then be
      carried out on 3 populations:

        -  Hypercapnic exacerbation of chronic obstructive pulmonary disease

        -  Hypoxic acute respiratory distress on infectious lung disease

        -  Acute pulmonary edema
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 5, 2019</start_date>
  <completion_date type="Anticipated">October 5, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 5, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Thickening fraction</measure>
    <time_frame>48 hours</time_frame>
    <description>Measurement of the thickening fraction by diaphragmatic ultrasound</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">201</enrollment>
  <condition>Respiratory Distress Syndrome,Adult</condition>
  <arm_group>
    <arm_group_label>ultrasound examination</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Assess the prevalence of acute diaphragmatic dysfunction by ultrasound</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>ultrasound examination</intervention_name>
    <description>Measuring the thickening fraction by diaphragmatic ultrasound of acute diaphragmatic dysfunction in patients admitted for acute respiratory distress</description>
    <arm_group_label>ultrasound examination</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hospitalization for acute respiratory distress management

          -  Etiological diagnosis either:

          -  Exacerbation of chronic obstructive pulmonary disease

          -  Infectious pneumonitis

          -  Acute pulmonary edema

          -  Need for a ventilatory support by either:

          -  Non-invasive ventilation

          -  High flow oxygen therapy (flow rate &gt; 40L/min and oxygen inspired fraction &gt; 40%)

          -  Mask oxygen therapy with flow rate &gt; 5L/min

        Exclusion Criteria:

          -  Exacerbation of interstitial pathology / pulmonary fibrosis

          -  Deformation of the thoracic cage

          -  Neurodegenerative pathology

          -  Need for oro-tracheal intubation from the beginning for mechanical ventilation

          -  Contraindication to Non-invasive Ventilation

          -  Patients undergoing diaphragmatic rehabilitation

          -  Immunocompromised patients

          -  History of known diaphragmatic dysfunction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Céline SANFIORENZO, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Nice</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Céline SANFIORENZO, MD</last_name>
    <phone>492038057</phone>
    <phone_ext>+33</phone_ext>
    <email>sanfiorenzo.c@chu-nice.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Nice</name>
      <address>
        <city>Nice</city>
        <zip>06003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Céline SANFIORENZO, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 25, 2019</study_first_submitted>
  <study_first_submitted_qc>September 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 26, 2019</study_first_posted>
  <last_update_submitted>November 20, 2019</last_update_submitted>
  <last_update_submitted_qc>November 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

